|
Sciclone Pharmaceuticals has the Highest Future Earnings Growth in the Biotechnology Industry (SCLN, CPHD, REGN, ALXN, ANIK)
Feb 04, 2013 (SmarTrend(R) News Watch via COMTEX) --
Below are the three companies in the Biotechnology industry with the highest future earnings growth. The growth of earnings per share (next fiscal year estimated vs. current fiscal year estimated) is important to gauge future profitability and relative value. Higher EPS growth generally justifies higher earnings multiples.Sciclone Pharmaceuticals ranks highest with a future earnings growth of 195.5%. Following is Cepheid with a future earnings growth of 69.8%. Regeneron Pharmaceuticals ranks third highest with a future earnings growth of 40.7%.
Alexion Pharmaceuticals follows with a future earnings growth of 36.9%, and Anika Therapeutics rounds out the top five with a future earnings growth of 23.2%.
SmarTrend recommended that its subscribers protect gains by selling shares of Anika Therapeutics on October 12th, 2012 by issuing a Downtrend alert when the shares were trading at $13.31. Since that call, shares of Anika Therapeutics have fallen 18.9%. We are now looking for when a new Uptrend will commence and will alert SmarTrend subscribers in real time.
Write to Chip Brian at cbrian@mysmartrend.com
---------------------------------------------------------------------------------------------
SmarTrend analyzes over 5,000 securities simultaneously throughout the trading day and provides its subscribers with trend change alerts in real time. To get a free trial of our trading calls and maximize your trading results, please visit http://www.MySmarTrend.com
Get exclusive, actionable insight into how the market is expected to trend prior to market open with our free morning newsletter. Sign up at: http://www.MySmarTrend.com/signup
[ Back To Technology News's Homepage ]
|